D.C. Circuit Rejects Oncologists’ Challenge to Medicare Sequestration Cuts for Cancer Drugs
- February 19, 2021
The D.C. Circuit affirmed February 16 the dismissal of an action challenging a 2% reduction in Medicare drug reimbursement for certain cancer drugs under Part B for lack of subject matter jurisdiction.
You must be logged in to access this content.